Fluzone Quadrivalent 2025-2026 high dose vaccine 0.7 ML Prefilled Syringe
- RxCUI
- 2719414
- RxNorm name
- Fluzone Quadrivalent 2025-2026 high dose vaccine 0.7 ML Prefilled Syringe
- Display name
- Fluzone Quadrivalent 2025-2026 high dose vaccine 0.7 ML Prefilled Syringe
- Full name
- Fluzone Quadrivalent 2025-2026 high dose vaccine 0.7 ML Prefilled Syringe
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 03f2c9fc-534b-49ec-9113-81938b1eadb9 | Fluzone Quadrivalent 2025-2026 high dose vaccine 0.7 ML Prefilled Syringe [PSN] · 0.7 ML influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2025-2026] [SBD] · Fluzone Quadrivalent 2025-2026 high dose vaccine 0.7 ML Prefilled Syringe [SY] | 3 | 20 | These highlights do not include all the information needed to use Fluzone ® High-Dose Quadrivalent safely and effectively. See full prescribing information for Fluzone High-Dose Quadrivalent. Fluzone High-Dose Quadrivalent (Influenza Vaccine) injectable suspension, for intramuscular use 2025-2026 Formula Initial U.S. Approval: 2019 | 20250711 |